Peripartum kardiomyopati

Ditte-Marie Bretler, Casper Haslund Jørgensen, Jonas Bjerring Olesen, Gunnar Hilmar Gislason, Peter Riis Hansen


    Peripartum cardiomyopathy is a rare and potentially fatal disease with peripartum heart failure in previously healthy women. A brief review of the literature is provided with emphasis on recent data indicating that an antiangiogenic cleavage product of prolactin contributes to the molecular mechanisms underlying peripartum cardiomyopathy, and that blocking the release of prolactin with bromocriptine can ameliorate the condition.
    Bidragets oversatte titel[Peripartum cardiomyopathy]
    TidsskriftUgeskrift for Laeger
    Udgave nummer1-2
    Sider (fra-til)53-5
    Antal sider3
    StatusUdgivet - 5 jan. 2009


    Dyk ned i forskningsemnerne om 'Peripartum kardiomyopati'. Sammen danner de et unikt fingeraftryk.